英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

eleventh    音标拼音: [ɪl'ɛvənθ] ['ilɛvənθ]
num. 第十一,11号

第十一,11号

eleventh
adj 1: coming next after the tenth and just before the twelfth
in position [synonym: {eleventh}, {11th}]
n 1: position 11 in a countable series of things

Eleventh \E*lev"enth\, a. [Cf. AS. endlyfta. See {Eleven}.]
1. Next after the tenth; as, the eleventh chapter.
[1913 Webster]

2. Constituting one of eleven parts into which a thing is
divided; as, the eleventh part of a thing.
[1913 Webster]

3. (Mus.) Of or pertaining to the interval of the octave and
the fourth.
[1913 Webster]


Eleventh \E*lev"enth\, n.
1. The quotient of a unit divided by eleven; one of eleven
equal parts.
[1913 Webster]

2. (Mus.) The interval consisting of ten conjunct degrees;
the interval made up of an octave and a fourth.
[1913 Webster]

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Myelodysplastic syndromes: Updates on Genomic Landscape . . .
    Purpose of Review Advances in modern molecular and genomic testing have spurred tremendous progress in our understanding of MDS pathogenesis Here we review common diagnostic methods, the evolving multi-omics landscape of MDS, molecular subtypes, and targeted therapies Recent Findings MDS is a heterogeneous disease defined by a wide array of chromosomal abnormalities and > 40 common somatic
  • Whats New in Myelodysplastic Syndrome (MDS) Research?
    As researchers have learned more about the gene changes inside MDS cells, they’ve started to test drugs that target some of these changes An example is ivosidenib (Tibsovo), which can now be used to treat MDS when the cells have an IDH1 gene mutation Many other targeted therapy drugs are now being studied for use against MDS as well
  • Genetics of MDS | Blood | American Society of Hematology
    Myelodysplastic syndromes (MDS) comprises a heterogeneous group of myeloid neoplasms, which are characterized in common by manifestations of bone marrow failure with abnormal cell morphology and a high propensity to acute myeloid leukemia (AML) 1, 2 Now, it is well recognized that MDS is, like other cancers, shaped by recursive rounds of positive selections, where gene mutations and other
  • Myelodysplasia after Lentiviral Gene Therapy | New England . . .
    To the Editor: Duncan et al (Oct 10 issue)1 report the occurrence of myelodysplastic syndrome in approximately 10% of patients with cerebral adrenoleukodystrophy who received autologous hematopoi
  • Hotspot gene mutations and treatment response in . . . - Frontiers
    Abstract The myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders characterized by cytopenia and a high risk of transformation to acute myeloid leukemia In recent years, next-generation sequencing (NGS) has revealed common hotspot gene mutations in MDS, which are not only involved in disease progression, but also affect the responsiveness of different therapeutic
  • Target therapy adoption for myelodysplastic syndromes (MDS . . .
    This study evaluates MT use in first-line therapy decisions and its impact on treatment for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) Methods: This retrospective study analyzed genomic data from July 2018 to December 2023, sourced from NeoGenomics Laboratories and linked with Symphony administrative claims data
  • Myelodysplastic syndromes - Diagnosis and treatment - Mayo Clinic
    Medications that suppress or control your immune system are used in certain myelodysplastic syndromes to reduce your need for red blood cell transfusions Help people with a certain genetic abnormality If your myelodysplastic syndrome is associated with a gene mutation called isolated del (5q), your doctor might recommend lenalidomide (Revlimid)
  • Targeted therapy with the mutant IDH2 inhibitor enasidenib . . .
    The isocitrate dehydrogenase enzyme 2 (IDH2) gene is mutated in ∼5% of patients with myelodysplastic syndrome (MDS) Enasidenib is an oral, selective,…
  • Critical Updates in TP53 MDS Prognosis: 2025 Findings
    The prevalence of TP53 mutations varies significantly across myeloid neoplasms, occurring in approximately 8-12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) cases, whereas therapy-related myeloid neoplasms show much higher frequencies, ranging from 20-40%





中文字典-英文字典  2005-2009